Amy Ziemba

598 total citations
18 papers, 488 citations indexed

About

Amy Ziemba is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Amy Ziemba has authored 18 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Amy Ziemba's work include Biochemical and Molecular Research (5 papers), RNA Interference and Gene Delivery (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Amy Ziemba is often cited by papers focused on Biochemical and Molecular Research (5 papers), RNA Interference and Gene Delivery (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Amy Ziemba collaborates with scholars based in United States, Hong Kong and Denmark. Amy Ziemba's co-authors include Giuseppe Pizzorno, Yasuyo Urasaki, Thuc T. Le, Eugene D Hayes, Michael W. Collard, Jodi I. Huggenvik, Rhett J. Michelson, Scot Ebbinghaus, Gary Kleiger and Kerri Mowen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Amy Ziemba

18 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Ziemba United States 13 360 77 66 53 42 18 488
Kwangman Choi South Korea 10 269 0.7× 57 0.7× 42 0.6× 50 0.9× 33 0.8× 12 442
Manish C. Pathak United States 8 297 0.8× 64 0.8× 97 1.5× 71 1.3× 23 0.5× 8 483
Taeko Yamauchi Japan 15 265 0.7× 160 2.1× 52 0.8× 41 0.8× 24 0.6× 24 548
Tine Skovgaard Denmark 8 483 1.3× 69 0.9× 125 1.9× 49 0.9× 31 0.7× 12 650
Vanya Shah India 10 331 0.9× 28 0.4× 41 0.6× 59 1.1× 22 0.5× 12 479
Shankang Qi China 10 539 1.5× 40 0.5× 60 0.9× 47 0.9× 98 2.3× 13 663
Andra M. Sterea Canada 13 269 0.7× 56 0.7× 84 1.3× 65 1.2× 78 1.9× 14 501
K. Bhavani United States 11 260 0.7× 58 0.8× 38 0.6× 18 0.3× 21 0.5× 13 411
Hilde Nebb Sørensen Norway 10 335 0.9× 50 0.6× 40 0.6× 36 0.7× 62 1.5× 15 458
Marilyn Carrier Canada 9 600 1.7× 72 0.9× 82 1.2× 25 0.5× 39 0.9× 10 873

Countries citing papers authored by Amy Ziemba

Since Specialization
Citations

This map shows the geographic impact of Amy Ziemba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ziemba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ziemba more than expected).

Fields of papers citing papers by Amy Ziemba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Ziemba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ziemba. The network helps show where Amy Ziemba may publish in the future.

Co-authorship network of co-authors of Amy Ziemba

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Ziemba. A scholar is included among the top collaborators of Amy Ziemba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Ziemba. Amy Ziemba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hill, Spencer, et al.. (2014). Ubiquitin-conjugating Enzyme Cdc34 and Ubiquitin Ligase Skp1-Cullin-F-box Ligase (SCF) Interact through Multiple Conformations. Journal of Biological Chemistry. 290(2). 1106–1118. 19 indexed citations
2.
Le, Thuc T., et al.. (2013). Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation. Journal of Lipid Research. 54(4). 1044–1057. 93 indexed citations
3.
Huang, Hao, Derek F. Ceccarelli, Stephen Orlicky, et al.. (2013). E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin. Nature Chemical Biology. 10(2). 156–163. 70 indexed citations
4.
Ziemba, Amy, et al.. (2013). Multimodal Mechanism of Action for the Cdc34 Acidic Loop. Journal of Biological Chemistry. 288(48). 34882–34896. 16 indexed citations
5.
Le, Thuc T., et al.. (2012). Label-free Evaluation of Hepatic Microvesicular Steatosis with Multimodal Coherent Anti-Stokes Raman Scattering Microscopy. PLoS ONE. 7(11). e51092–e51092. 36 indexed citations
6.
Roosild, Tarmo P., et al.. (2011). A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity. Journal of Structural Biology. 176(2). 229–237. 22 indexed citations
7.
Ziemba, Amy, Eugene D Hayes, Burgess B. Freeman, Tao Ye, & Giuseppe Pizzorno. (2011). Development of an Oral Form of Azacytidine: Triacetyl-5-Azacytidine. PubMed. 2011. 1–9. 14 indexed citations
8.
Cao, Deliang, Amy Ziemba, James L. McCabe, et al.. (2011). Differential Expression of Uridine Phosphorylase in Tumors Contributes to an Improved Fluoropyrimidine Therapeutic Activity. Molecular Cancer Therapeutics. 10(12). 2330–2339. 14 indexed citations
9.
Cao, Deliang, et al.. (2010). Activation of Stat1, IRF-1, and NF-κB is Required for the Induction of Uridine Phosphorylase by Tumor Necrosis Factor-α and Interferon-γ. Nucleosides Nucleotides & Nucleic Acids. 29(4-6). 488–503. 9 indexed citations
10.
Cottam, Daniel, Barry L. Fisher, Amy Ziemba, et al.. (2010). Tumor growth factor expression in obesity and changes in expression with weight loss: another cause of increased virulence and incidence of cancer in obesity. Surgery for Obesity and Related Diseases. 6(5). 538–541. 18 indexed citations
11.
Gao, Yang, Amy Ziemba, Jennifer Turner, & Giuseppe Pizzorno. (2010). Abstract 52: Overexpression of uridine phosphorylase 2 (UPP2) in tissues of uridine phosphorylase (UPP1) knock-out mice. Cancer Research. 70(8_Supplement). 52–52. 1 indexed citations
12.
Ziemba, Amy, et al.. (2006). PNA−Nitrogen Mustard Conjugates Are Effective Suppressors of HER-2/neu and Biological Tools for Recognition of PNA/DNA Interactions. Bioconjugate Chemistry. 17(1). 214–222. 14 indexed citations
13.
Ziemba, Amy, et al.. (2005). Targeting and Regulation of the HER-2/neu Oncogene Promoter with Bis-Peptide Nucleic Acids. Oligonucleotides. 15(1). 36–50. 7 indexed citations
14.
Ziemba, Amy, et al.. (2005). Peptide Nucleic Acid Conjugates: Synthesis, Properties and Applications. Current Topics in Medicinal Chemistry. 5(12). 1119–1131. 31 indexed citations
15.
Ziemba, Amy, John O. Trent, Michael W. Reed, et al.. (2004). Synthesis and Evaluation of a Triplex-Forming Oligonucleotide−Pyrrolobenzodiazepine Conjugate. Bioconjugate Chemistry. 15(6). 1182–1192. 8 indexed citations
16.
Ziemba, Amy, Michael W. Reed, Kevin D. Raney, Alicia K. Byrd, & Scot Ebbinghaus. (2003). A Bis-Alkylating Triplex Forming Oligonucleotide Inhibits Intracellular Reporter Gene Expression and Prevents Triplex Unwinding Due to Helicase Activity. Biochemistry. 42(17). 5013–5024. 6 indexed citations
17.
Michelson, Rhett J., Michael W. Collard, Amy Ziemba, et al.. (1999). Nuclear DEAF-1-related (NUDR) Protein Contains a Novel DNA Binding Domain and Represses Transcription of the Heterogeneous Nuclear Ribonucleoprotein A2/B1 Promoter. Journal of Biological Chemistry. 274(43). 30510–30519. 44 indexed citations
18.
Huggenvik, Jodi I., et al.. (1998). Characterization of a Nuclear Deformed Epidermal Autoregulatory Factor-1 (DEAF-1)-Related (NUDR) Transcriptional Regulator Protein. Molecular Endocrinology. 12(10). 1619–1639. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026